Alight (NYSE:ALIT) Issues FY23 Earnings Guidance
Alight (NYSE:ALIT – Get Free Report) issued an update on its FY23 earnings guidance on Wednesday morning. The company provided EPS guidance of $0.65-0.69 for the period, compared to the consensus EPS estimate of $0.64. The company issued revenue guidance of $3.47-3.51 billion, compared to the consensus revenue estimate of $3.50 billion. Alight Stock Performance […]
More Stories
Contrasting Geo Group (NYSE:GEO) & ICF International (NASDAQ:ICFI)
ICF International (NASDAQ:ICFI – Get Free Report) and Geo Group (NYSE:GEO – Get Free Report) are both business services companies,...
UBS Group Initiates Coverage on Summit Therapeutics (NASDAQ:SMMT)
Stock analysts at UBS Group started coverage on shares of Summit Therapeutics (NASDAQ:SMMT – Get Free Report) in a research...
C.H. Robinson Worldwide (NASDAQ:CHRW) Raised to “Outperform” at Wolfe Research
C.H. Robinson Worldwide (NASDAQ:CHRW – Get Free Report) was upgraded by research analysts at Wolfe Research from a “peer perform”...
Omada Health (NASDAQ:OMDA) Now Covered by JPMorgan Chase & Co.
Investment analysts at JPMorgan Chase & Co. began coverage on shares of Omada Health (NASDAQ:OMDA – Get Free Report) in...
Roth Capital Reiterates “Neutral” Rating for Hecla Mining (NYSE:HL)
Hecla Mining (NYSE:HL – Get Free Report)‘s stock had its “neutral” rating restated by stock analysts at Roth Capital in...
INmune Bio’s (INMB) “Neutral” Rating Reiterated at BTIG Research
INmune Bio (NASDAQ:INMB – Get Free Report)‘s stock had its “neutral” rating reiterated by stock analysts at BTIG Research in...